Chemical & MaterialTop Companies
Chemical & Material

Top Abdominal Aortic Aneurysm (AAA) Repair Devices Market Companies - Rankings, Profiles, Market Share, SWOT & Strategic Outlook

Industry

Chemical & Material

Published

Jan 2026

Share:

Chemical & Material

Top Abdominal Aortic Aneurysm (AAA) Repair Devices Market Companies - Rankings, Profiles, Market Share, SWOT & Strategic Outlook

$3,590

Choose License Type

Only one user can use this report

Additional users can access this report

You can share within your company

Company Contents

Quick Facts & Snapshot

2025 Market Size (US$)
3.30 Billion
2026 Forecast (US$)
3.53 Billion
2032 Forecast (US$)
5.27 Billion
CAGR (2025-2032)
6.90%

Summary

The Abdominal Aortic Aneurysm (AAA) Repair Devices market is entering a consolidation-driven growth phase, underpinned by rising endovascular preference and stricter safety standards. Leading vendors are competing on durability, delivery precision, and post-procedure outcomes while defending share through M&A and portfolio breadth. Global revenues are expected to increase from US$ 3.30 Billion in 2025 to US$ 5.27 Billion by 2032, reflecting a 6.90% CAGR.

2025 Revenue of Top Abdominal Aortic Aneurysm (AAA) Repair Devices Suppliers
ReportMines Logo

Source: Secondary Information and ReportMines Research Team - 2026

Ranking Methodology

Rankings of Abdominal Aortic Aneurysm (AAA) Repair Devices market companies are derived from a composite scoring framework that blends quantitative and qualitative indicators. Quantitatively, we assess 2025 segment revenue, EVAR/TEVAR procedure penetration, installed base of stent grafts and delivery systems, and regional revenue diversification. Qualitatively, we evaluate technology differentiation, clinical evidence strength, portfolio breadth across infrarenal and juxtarenal anatomies, customization capabilities, and breadth of after-sales service and training programs. Additional weight is assigned to long-term maintenance contracts, inventory management services, and ability to support complex, high-risk patients. Strategic actions, including acquisitions, regulatory approvals, pivotal trial milestones, and key hospital network wins, refine final positions. Each vendor receives a normalized score, and Abdominal Aortic Aneurysm (AAA) Repair Devices market companies are then ranked from 1 to 10 based on their aggregate performance.

Top 10 Companies in Abdominal Aortic Aneurysm (AAA) Repair Devices

1
Medtronic plc
Endurant II/IIs, Endurant II S, Heli-FX EndoAnchor System
Dublin, Ireland
Improved conformability, lower-profile delivery systems, and durability data from long-term registries.
Endovascular AAA stent graft systems, delivery catheters, and imaging-supported EVAR solutions.
29.70%
US$ 980.00 Million
North America, Western Europe, Japan
Multi-year EVAR framework agreements with large U.S. IDNs and selected NHS trusts.
Portfolio optimization for complex anatomies, expanded IFU in major markets, and integration of imaging guidance with leading OEMs.
2
W. L. Gore & Associates, Inc.
Gore Excluder AAA Endoprosthesis, C3 Delivery System, Gore TAG Device
Newark, USA
Long-term graft durability, enhanced sealing in short-neck aneurysms, and simplified deployment techniques.
ePTFE-based endovascular stent grafts and accessories for AAA and thoracic aortic repair.
21.80%
US$ 720.00 Million
United States, Germany, United Kingdom, Australia
Preferred-supplier status in several U.S. academic medical centers and regional hospital chains.
Clinical expansion into challenging neck anatomies and post-market surveillance programs across Europe and North America.
3
Cook Medical LLC
Zenith Flex AAA Endovascular Graft, Zenith Alpha, Zenith Fenestrated
Bloomington, USA
Fenestrated/branched technology, customized sizing, and procedural workflow simplification.
Customizable AAA stent grafts and physician-modified solutions for complex anatomies.
15.80%
US$ 520.00 Million
North America, Europe, Australia
Complex EVAR reference-center collaborations in the U.S., UK, and Scandinavia.
Expansion of fenestrated and branched platforms and increased focus on physician-training programs for complex EVAR.
4
Terumo Corporation
Anaconda AAA Stent Graft System, Relieva Delivery Systems
Tokyo, Japan
Low-profile systems, improved flexibility, and compatibility with smaller access vessels.
Endovascular grafts and access solutions targeting Asian and global markets.
8.20%
US$ 270.00 Million
Japan, broader Asia Pacific, selected European markets
Key reference sites in Japan and Korea for minimally invasive EVAR programs.
Integration of vascular access portfolios with AAA devices and geographic expansion in Asia Pacific and Latin America.
5
Endologix LLC
AFX2 Endovascular AAA System, Nellix EVAS (legacy/selected markets)
Irvine, USA
Next-generation sealing concepts and durability evidence to address prior safety concerns.
Novel endovascular sealing technologies for AAA with a focus on sac-based repair.
5.80%
US$ 190.00 Million
United States, select EU markets, Middle East
Adoption in niche high-volume EVAR centers focusing on specific anatomies.
Refinement of indications, post-market clinical follow-up programs, and select-market relaunch strategies.
6
Jotec GmbH (CryoLife/Artivion)
E-Vita, E-ventus, Jotec Endovascular Grafts
Hechingen, Germany
Hybrid graft designs, improved branch configurations, and alignment with cardiac surgery workflows.
AAA and thoracoabdominal stent grafts, particularly for complex and hybrid surgical approaches.
3.90%
US$ 130.00 Million
Germany, broader DACH region, Eastern Europe
Hybrid OR centers in Germany and Austria specializing in aortic arch and abdominal disease.
Synergy programs with cardiac surgery portfolios and expansion in Central/Eastern Europe.
7
Abbott Laboratories (Vascular Portfolio)
AAA-related stent graft accessories, vascular closure and imaging adjuncts
Abbott Park, USA
Imaging-guided deployment, vascular closure optimization, and data-enabled procedure support.
Endovascular and vascular access technologies leveraging broad cardiovascular footprint.
3.30%
US$ 110.00 Million
United States, Western Europe, China
Integrated cath-lab and vascular lab solutions for multi-disciplinary aortic centers.
Bundled cardiovascular solutions and integration with imaging and hemodynamic monitoring platforms.
8
Cardinal Health / Cordis (legacy EVAR portfolio)
Cordis EVAR Systems, vascular access solutions
Dublin, Ireland
Incremental updates and cost-optimized configurations rather than radical innovation.
Legacy EVAR devices and vascular accessories with strong distribution reach.
2.70%
US$ 90.00 Million
Latin America, parts of Europe, Middle East
Retendered supply contracts with existing EVAR users.
Portfolio rationalization and focus on select geographies where installed base is strong.
9
MicroPort Scientific Corporation
MicroPort AAA Stent Graft Series
Shanghai, China
Cost-effective designs, local anatomical fit, and faster approval cycles.
Cost-competitive AAA stent grafts tailored for Chinese and emerging-market anatomies.
2.40%
US$ 80.00 Million
China, Southeast Asia, Latin America (early stage)
Large provincial hospital networks in China via centralized tenders.
Domestic tenders in China and stepped-up regulatory filings in Southeast Asia and Latin America.
10
Lifetech Scientific
Lifetech AAA Stent Graft Platform
Shenzhen, China
Lower-profile systems, simplified deployment, and global regulatory alignment.
Endovascular aortic repair devices and peripheral vascular solutions for emerging markets.
2.10%
US$ 70.00 Million
China, selected ASEAN markets, Middle East
Public procurement wins in tier-2 Chinese cities and Gulf states.
Broader Asia Pacific rollout and investment in international clinical trials.

Source: Secondary Information and ReportMines Research Team - 2026

Detailed Company Profiles

1

Medtronic plc

Global cardiovascular technology leader with the broadest commercial EVAR portfolio and deep penetration across high-volume aortic repair centers.

Key Financials: 2025 Abdominal Aortic Aneurysm (AAA) Repair Devices revenue US$ 980.00 Million; segment growth 6.90% aligned with overall market CAGR.
Flagship Products: Endurant II/IIs, Endurant II S, Heli-FX EndoAnchor System
2025-2026 Actions: Expanded complex EVAR indications, invested in imaging integration, and deepened training partnerships with leading vascular societies.
Three-line SWOT: Strong global installed base and brand recognition; High price points versus regional challengers; Opportunity—aging populations drive higher AAA screening and EVAR volumes.
Notable Customers: Cleveland Clinic, Mayo Clinic, NHS vascular centers
2

W. L. Gore & Associates, Inc.

Privately held materials and medical-device innovator recognized for durable ePTFE-based AAA stent graft systems and robust clinical data.

Key Financials: 2025 Abdominal Aortic Aneurysm (AAA) Repair Devices revenue US$ 720.00 Million; R&D spend intensity estimated above 8.00% of segment sales.
Flagship Products: Gore Excluder AAA Endoprosthesis, C3 Delivery System, Gore TAG Device
2025-2026 Actions: Expanded post-market registries, advanced neck-challenging indication studies, and reinforced key-center relationships in Europe and North America.
Three-line SWOT: Highly trusted brand with strong durability evidence; Limited exposure in price-sensitive emerging markets; Opportunity—complex neck solutions and guideline inclusion expansions.
Notable Customers: Massachusetts General Hospital, University Hospital Zurich, Royal Free London
3

Cook Medical LLC

Specialist in customizable and complex EVAR solutions, particularly fenestrated and branched stent grafts for challenging aortic anatomies.

Key Financials: 2025 Abdominal Aortic Aneurysm (AAA) Repair Devices revenue US$ 520.00 Million; complex-EVAR subsegment growth estimated above 8.50% annually.
Flagship Products: Zenith Flex AAA Endovascular Graft, Zenith Alpha, Zenith Fenestrated
2025-2026 Actions: Scaled physician-modified graft programs, broadened training on fenestrated procedures, and strengthened collaboration with hybrid OR centers.
Three-line SWOT: Strong reputation in complex AAA repairs; Longer lead times for customized devices; Opportunity—rising case complexity at high-volume vascular centers globally.
Notable Customers: Cleveland Clinic, St. George’s Hospital London, Australian tertiary hospitals
4

Terumo Corporation

Diversified Japanese medtech player leveraging endovascular expertise and distribution strength to grow its AAA stent graft footprint.

Key Financials: 2025 Abdominal Aortic Aneurysm (AAA) Repair Devices revenue US$ 270.00 Million; double-digit growth in Asia Pacific offsetting slower Europe.
Flagship Products: Anaconda AAA Stent Graft System, Relieva Delivery Systems
2025-2026 Actions: Integrated vascular access and EVAR offerings, accelerated Asia Pacific expansion, and broadened post-market surveillance initiatives.
Three-line SWOT: Strong brand in Japan and Asia; Relatively limited U.S. presence; Opportunity—rapid EVAR adoption in emerging Asian and Latin American markets.
Notable Customers: Japanese university hospitals, major Korean teaching hospitals, Australian public hospitals
5

Endologix LLC

Focused EVAR company emphasizing unique sac-sealing technologies and niche positioning in anatomically selective AAA repair.

Key Financials: 2025 Abdominal Aortic Aneurysm (AAA) Repair Devices revenue US$ 190.00 Million; revenues stabilizing after portfolio rationalization and safety-related resets.
Flagship Products: AFX2 Endovascular AAA System, Nellix EVAS (legacy/selected markets)
2025-2026 Actions: Enhanced surveillance protocols, refined indication labeling, and targeted re-engagement with specialized EVAR centers.
Three-line SWOT: Innovative sealing concept for specific anatomies; Historical safety concerns constrain adoption; Threat—stringent regulatory oversight on novel EVAR technologies.
Notable Customers: Selected U.S. EVAR reference centers, European high-volume aneurysm clinics
6

Jotec GmbH (CryoLife/Artivion)

European aortic specialist offering hybrid and endovascular graft solutions that bridge cardiac surgery and vascular interventions.

Key Financials: 2025 Abdominal Aortic Aneurysm (AAA) Repair Devices revenue US$ 130.00 Million; strong contribution from hybrid procedures in DACH markets.
Flagship Products: E-Vita, E-ventus, Jotec Endovascular Grafts
2025-2026 Actions: Aligned aortic portfolios with cardiac surgery solutions and expanded in Central and Eastern Europe with new distributors.
Three-line SWOT: Deep expertise in complex aortic cases; Smaller scale than global leaders; Opportunity—growth of hybrid ORs and multi-disciplinary aortic centers.
Notable Customers: German university hospitals, Austrian hybrid OR centers, leading Eastern European cardiac institutes
7

Abbott Laboratories (Vascular Portfolio)

Global cardiovascular company leveraging vascular and imaging platforms to participate in the AAA repair value chain.

Key Financials: 2025 Abdominal Aortic Aneurysm (AAA) Repair Devices revenue US$ 110.00 Million; AAA-related accessories complement a multi-billion-dollar vascular franchise.
Flagship Products: AAA-related stent graft accessories, vascular closure devices, imaging adjuncts
2025-2026 Actions: Pursued bundled cardiovascular deals and integrated imaging and hemodynamic tools to support EVAR workflows.
Three-line SWOT: Broad hospital relationships and cross-selling scale; EVAR-specific portfolio less comprehensive; Opportunity—bundled procurement and integrated procedural ecosystems.
Notable Customers: Major U.S. IDNs, European cath-lab and vascular networks, large Chinese tertiary hospitals
8

Cardinal Health / Cordis (legacy EVAR portfolio)

Distributor-led player maintaining a legacy EVAR portfolio with cost-focused propositions in specific geographies.

Key Financials: 2025 Abdominal Aortic Aneurysm (AAA) Repair Devices revenue US$ 90.00 Million; relatively flat growth reflecting mature installed base.
Flagship Products: Cordis EVAR Systems, vascular access solutions
2025-2026 Actions: Optimized SKU mix, prioritized profitable contracts, and exited low-margin markets for AAA devices.
Three-line SWOT: Extensive distribution infrastructure; Limited innovation pipeline for EVAR; Threat—replacement by newer-generation systems from major competitors.
Notable Customers: Latin American public hospitals, regional European centers, Middle Eastern government hospitals
9

MicroPort Scientific Corporation

Chinese medtech company emphasizing cost-effective AAA solutions tailored for local anatomy and public procurement environments.

Key Financials: 2025 Abdominal Aortic Aneurysm (AAA) Repair Devices revenue US$ 80.00 Million; double-digit domestic growth driven by centralized tenders.
Flagship Products: MicroPort AAA Stent Graft Series
2025-2026 Actions: Secured major provincial tenders, advanced Southeast Asia registrations, and invested in local clinical-data generation.
Three-line SWOT: Strong position in Chinese value segment; Limited brand recognition in Western markets; Opportunity—Belt and Road markets seeking affordable AAA devices.
Notable Customers: Provincial Chinese hospital networks, early adopters in Southeast Asia, select Latin American centers
10

Lifetech Scientific

Emerging Chinese aortic repair player expanding from domestic leadership toward broader international markets with value-oriented devices.

Key Financials: 2025 Abdominal Aortic Aneurysm (AAA) Repair Devices revenue US$ 70.00 Million; fastest percentage growth among smaller Chinese players.
Flagship Products: Lifetech AAA Stent Graft Platform
2025-2026 Actions: Scaled manufacturing, initiated multinational trials, and pursued regulatory approvals beyond China, especially in Asia and the Middle East.
Three-line SWOT: Competitive pricing and agile development; Limited long-term outcome data internationally; Opportunity—emerging-market hospital expansion and tender-based procurement.
Notable Customers: Tier-2 Chinese hospitals, Gulf-region public hospitals, ASEAN vascular centers

SWOT Leaders

Medtronic plc

SWOT Snapshot

SWOT
Strengths

Largest global EVAR share, comprehensive AAA portfolio, and strong clinical evidence across multiple geographies and patient profiles.

Weaknesses

Premium pricing and complex portfolio can challenge procurement negotiations and inventory management for cost-constrained hospitals.

Opportunities

Increased AAA screening, aging populations, and migration of procedures to minimally invasive EVAR in emerging markets.

Threats

Price erosion from regional players and potential regulatory scrutiny on long-term device performance data.

W. L. Gore & Associates, Inc.

SWOT Snapshot

SWOT
Strengths

Highly trusted stent graft durability, distinctive materials expertise, and close collaborations with top aortic centers worldwide.

Weaknesses

Limited footprint in some high-growth, price-sensitive emerging markets where local players are winning tenders.

Opportunities

Growing demand for solutions in short-neck and hostile-neck anatomies and inclusion in updated treatment guidelines.

Threats

Competitive innovation in sealing technologies and increasing payer pressure on premium pricing segments.

Cook Medical LLC

SWOT Snapshot

SWOT
Strengths

Strong reputation in complex, fenestrated, and branched EVAR with deep relationships in advanced aortic centers.

Weaknesses

Customization can extend lead times and raise procedural planning complexity compared with off-the-shelf systems.

Opportunities

Global rise in complex aneurysm presentations and expansion of hybrid OR facilities supporting advanced techniques.

Threats

Regulatory requirements for individualized devices and competition from standardized complex-EVAR offerings by larger players.

Abdominal Aortic Aneurysm (AAA) Repair Devices Market Regional Competitive Landscape

North America remains the largest regional market, driven by high AAA screening rates, broad reimbursement coverage, and strong preference for EVAR over open repair. Medtronic plc and W. L. Gore & Associates, Inc. dominate premium segments, while Endologix LLC secures selective adoption in anatomically suitable patients at specialized vascular centers.

Western Europe shows mature yet resilient growth, supported by aging demographics and guideline-backed EVAR usage. Cook Medical LLC and Medtronic plc hold strong positions in complex aneurysm repair, while Jotec GmbH leverages its hybrid aortic portfolio in Germany and neighboring markets. Competitive tenders incentivize price discipline among leading Abdominal Aortic Aneurysm (AAA) Repair Devices market companies.

Asia Pacific is the fastest-growing region, with Japan and Australia representing high-value EVAR markets and China contributing rapid volume expansion. Terumo Corporation leads in Japan, while MicroPort Scientific Corporation and Lifetech Scientific drive affordability in China. Global Abdominal Aortic Aneurysm (AAA) Repair Devices market companies are expanding training and proctoring programs to address skill gaps.

Latin America and the Middle East exhibit emerging, underpenetrated AAA repair opportunities, constrained by budget limitations and uneven screening infrastructure. Cardinal Health / Cordis leverages distribution scale, while Medtronic plc and W. L. Gore & Associates, Inc. target reference centers. Localized training initiatives and strategic partnerships are essential to unlock EVAR procedure growth.

Central and Eastern Europe, including the DACH region, increasingly favor minimally invasive AAA procedures, supported by modernized vascular centers. Jotec GmbH, Cook Medical LLC, and Medtronic plc compete in complex repairs, often linked to hybrid cardiac surgery programs. Structured procurement frameworks reward Abdominal Aortic Aneurysm (AAA) Repair Devices market companies that provide comprehensive service, training, and inventory support.

Abdominal Aortic Aneurysm (AAA) Repair Devices Market Emerging Challengers & Disruptive Start-Ups

Emerging Challengers & Disruptive Start-Ups

AortaNova Medical
Disruptor
USA

Developing polymer-based AAA repair systems with on-table customization and integrated pressure monitoring to optimize sac sealing and long-term stability.

EndoShape BioDevices
Disruptor
Germany

Pursuing bioresorbable scaffold concepts for infrarenal aneurysms, aiming to reduce permanent metal load while maintaining durable exclusion.

SinoVasc Aortic Tech
Disruptor
China

Combines AI-powered pre-operative planning with locally manufactured stent grafts to deliver personalized AAA repair at lower cost for provincial hospitals.

VascuSight Analytics
Disruptor
United Kingdom

Cloud-native planning platform that integrates CT data, device catalogs, and anatomical libraries to guide optimal device sizing for Abdominal Aortic Aneurysm (AAA) Repair Devices market companies and clinicians.

HybridFlow Systems
Disruptor
France

Designing modular graft components for combined open and endovascular AAA procedures, enabling tailored solutions in hybrid OR environments.

Abdominal Aortic Aneurysm (AAA) Repair Devices Market Future Outlook & Key Success Factors (2026-2032)

From 2025 to 2031, cumulative investments in metro expansions and station safety upgrades are projected to surpass significant amounts. The total market will scale from US$ 2.27 Billionin 2025 to US$ 3.38 Billion by 2031, reflecting a 6.90% CAGR. Winning Abdominal Aortic Aneurysm (AAA) Repair Devices market companies will share several attributes. First, they will embed native IoT sensors, enabling predictive maintenance contracts that can double recurring revenue within five years. Second, modular design philosophies—interchangeable panels, plug-and-play controllers—will shorten installation windows and appeal to cost-sensitive public operators.

Localization strategies will also define competitive edges. Suppliers that establish regional assembly plants to meet content rules in India, Brazil, or the U.S. are likely to capture bonus points in tenders. Finally, sustainability credentials will move from optional to mandatory. Recyclable composite panels, energy-efficient brushless motors, and life-cycle carbon disclosures will become bid differentiators. In short, the coming decade rewards Abdominal Aortic Aneurysm (AAA) Repair Devicesmarket companies that marry digital intelligence with manufacturing agility and regulatory foresight.

Frequently Asked Questions

Find answers to common questions about this company report.